Of these, ten genes (CTSZ, EFEMP2, ITGA5, KDELR2, MDK, MICALL2, MAP 2 K3, PLAUR, SERPINE1 and SOCS3) can potentially classify patients with gliomas into different risk groups. This evidence concerns the gene MDK and central nervous system cancer.